Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹16.49
0.17 (1.04%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹13 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹10.66+54.7%
52W High₹21.3-22.6%
Current Price
₹16.49
Circuit Limits (5%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹15.67
Upper Circuit₹17.31
Reference Price
₹16.49
Investment Checklist
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹18.38
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹17.82
Volume divergence: Bullish (price down, volume up)
Unusual volume detected (3.7x average) — institutional activity likely
EMA(50) Crossover: Price crossed above EMA(50): Fresh bullish momentum signal.
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
47%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition | Bullish MA stack (20>50>200)
EMA20
16.81
EMA50
16.41
EMA200
14.74
Price Action
DOWNTREND
BEARISH
Higher Highs2
Higher Lows3
Lower Highs7
Lower Lows6
Support & Resistance Levels
Resistance (Above)
₹17.42
₹18.31
₹18.93
₹19.90
₹21.30
Support (Below)
₹16.19
₹15.84
₹14.98
₹14.17
₹13.50
Volume Analysis
TrendINCREASING
Change+157.40%
Unusual Volume
Yes (3.69x avg)
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹16.33
3% Risk₹16.00
5% Risk₹15.67
7% Risk (Custom)
₹15.34Technical Levels
1x ATR (Volatility)₹15.33
2x ATR (Swing)₹14.17
3x ATR (Trend)₹13.01
Immediate Support₹16.19
Moving Averages
EMA 50 (Trend)₹16.41
EMA 200 (Long-term)₹14.74
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹3,35,000 | ₹4,53,000 | ₹3,98,000 | ₹1,40,000 |
| Net Profit | ₹-10,69,000 | ₹-16,41,000 | ₹-17,54,000 | ₹-50,25,000 |
| EPS | ₹-0.13 | — | ₹-0.22 | ₹-0.62 |
| Operating Profit | ₹-11,39,000 | ₹-16,14,000 | ₹-16,25,000 | ₹-50,14,000 |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| ORTIN GLOBAL LIMITED | ₹16.49 | +1.04% | — | ₹13 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 22 Sept 2023 | Annual General Meeting | AGM |
| 23 Sept 2022 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
No news available at the moment.